Table 3 Fat distribution measurements and serum levels of study cohort
|  | Total, n = 39 Median (SD) | EEC, n = 25 Median (SD) | NEEC, n = 14 Median (SD) |
|---|---|---|---|
Fat distribution | |||
 BMI (kg/m2) | 26.9 (7.9) | 27.5 (9.0) | 26.1 (4.7) |
 WC (cm) | 95.3 (15.8) | 97.8 (17.9) | 93 (11.0) |
 TAV (cm3) | 7529 (4633) | 7487 (5161) | 7570 (3484) |
 VAV (cm3) | 2772 (1677) | 2861 (1741) | 2668 (1610) |
 SAV (cm3) | 4544 (3230) | 4556 (3669) | 4544 (2181) |
 VAV% (%) | 33.4 (8.2) | 32.5 (8.3) | 34.4 (8.2) |
Sex steroids | |||
 Estradiol (pmol/L) | 54 (38.4) | 49 (43.8) | 56 (27.2) |
 Androstenedione (nmol/L) | 1.8 (1.1) | 1.8 (1.1) | 1.7 (1.2) |
 Testosterone (nmol/L) | 0.7 (0.6) | 0.7 (0.6) | 0.6 (0.4) |
 DHEAS (μmol/L) | 2.4 (1.5) | 2.4 (1.3) | 2.31 (1.8) |
Lipids | |||
 Cholesterol (mmol/L) | 5.1 (1.4) | 5.8 (1.3)* | 3.8 (1.4)* |
 HDL (mmol/L) | 0.8 (0.4) | 0.8 (0.4) | 0.6 (0.4) |
 LDL (mmol/L) | 3.5 (1.2) | 3.8 (1.1)* | 2.6 (1.2)* |
 NHDL (mmol/L) | 4.3 (1.3) | 4.5 (1.3)* | 3.2 (1.3)* |
 Triglycerides (mmol/L) | 1.5 (0.6) | 1.5 (0.6) | 1.5 (0.4) |
 Chol/HDL ratio | 7 (3.4) | 7 (3.3) | 8 (3.5) |